Article
Lung-selective Cas13d-based nanotherapy inhibits lethal SARS-CoV-2 infection by targeting host protease <i>Ctsl</i>
2021-10-05
Abstract excerpt
<h4>SUMMARY</h4> The COVID-19 pandemic persists as a global health crisis for which curative treatment has been elusive. Development of effective and safe anti-SARS-CoV-2 therapies remains an urgent need. SARS-CoV-2 entry into cells requires specific host proteases including TMPRSS2 and Cathepsin L (Ctsl) 1–3 , but there has been no reported success in inhibiting host proteases for treatment of SARS-CoV-2 pathog...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- ac46e820-ac88-56f7-b55a-a30cad25a269
- DOI
- 10.1101/2021.10.03.462915
